AtriCure (ATRC) Reports In-Line Q3 EPS; Guides FY15 Revenue Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $61.51 +0.70%
EPS Growth %: -300.0%
Financial Fact:
Other: -32K
Today's EPS Names:
SFBC, KSBI, PVBK, More
EPS Growth %: -300.0%
Financial Fact:
Other: -32K
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $31.4 million versus the consensus estimate of $31.38 million.
AtriCure sees FY2015 revenue of $129.5-130.5 million, versus the consensus of $128.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Teradyne (TER) Tops Q3 EPS by 21c, Beats on Revenue; Offers Q4 EPS Guidance
- LPL Financial (LPLA) Tops Q3 EPS by 30c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
